Intellipharmaceutics International Inc. (IPCI)

[wimuskyfisherman]

This will be one of my last posts of the year. I am not expecting IPCI to announce anything this year. I don't know anything, just the vibe I am getting... But I am optimistic for 2018. Here is what I see:

1. Focalin sales will be solid and deliver about $1-1.25M per quarter or roughly $4-5M in FY 2018.
2. Seroquel sales will continue to ramp up. This will be slow but by mid 2018 I think we will be seeing some nice revenue rolling in on Seroquel.
3. There will be at least one ANDA approval early in 2018.
4. At least one additional product will be commercialized in early 2018 and by around mid 2018 CFP status may be achieved. I think this can be done with Focalin, Seroquel and one other commercialized product. No guarantees here but if either Pritiq or Lamictal is approved in early 2018, then I would say this is for certain.
5. IPCI will complete the Rexista HAP studies roughly 3/4 the way through 2018. They will then ready to resubmit.
6. IPCI will hopefully resolve Purdue lawsuit.
7. PODRAS first clinical studies on humans will commence some time in 2018. Hopefully we will hear of results some time in 2018.

I know there is more that can and may happen, but I think that is a pretty good timeline on what at a minimum should happen with proper execution.

Happy Holidays All!